Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 33342-074

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 33342-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

A line chart showing the percentage of patients with systolic blood pressure (SBP) below 140 mmHg across different baseline SBP values ranging from 140 to 180 mmHg. The chart compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. Each group's trend is represented with different markers, illustrating treatment efficacy in lowering SBP.*

FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

A line graph showing the percentage of patients with diastolic blood pressure less than 90 mmHg (% DBP<90) plotted against baseline diastolic blood pressure (DBP) in mmHg. The graph compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, illustrating their effects on DBP.*

FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

A line graph depicting the percentage of subjects achieving systolic blood pressure (SBP) below 130 mmHg, plotted against baseline SBP (mmHg). Four treatment groups are compared: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, each represented by different symbols.*

FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

A line graph depicting the percentage of subjects achieving a diastolic blood pressure (DBP) below 80 mmHg against baseline DBP values ranging from 90 to 110 mmHg. The graph compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, each represented by different markers.*

FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

Chemical structure of the active ingredient Valsartan, showing its molecular formula with various chemical groups including a biphenyl tetrazole ring and a carboxyl group.*

FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

Chemical structure of Valsartan and Hydrochlorothiazide showing the arrangement of atoms including chlorine, sulfur, nitrogen, and oxygen in the molecule.*

FDA Label Image

505 (Valsartan Hctz 80 12 5 90s Baddi)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 80 mg/12.5 mg, film-coated tablets. The label specifies each tablet contains 80 mg Valsartan and 12.5 mg Hydrochlorothiazide. It also shows storage instructions and manufacturer details, including Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. The package contains 90 tablets.*

FDA Label Image

505 (Valsartan Hctz 80 12 5 90s Daman)

Valsartan and Hydrochlorothiazide Tablets USP 80 mg/12.5 mg film-coated tablets label. Manufactured by Macleods Pharmaceuticals Ltd and distributed by Macleods Pharma USA, Inc. Contains 90 tablets. Storage instructions specify 20° to 25°C with permitted excursions, and a note to dispense with the attached patient information leaflet.*

FDA Label Image

505 (Valsartan Hctz 160 12 5 90s Baddi)

Label for Valsartan and Hydrochlorothiazide Tablets USP, 160 mg/12.5 mg, film-coated tablets. The label specifies storage conditions and directs to see prescribing information for dosage. Manufactured by Macleods Pharmaceuticals Ltd, India, for Macleods Pharma USA, Inc. The package contains 90 tablets.*

FDA Label Image

505 (Valsartan Hctz 160 12 5 90s Daman)

Label for Valsartan and Hydrochlorothiazide Tablets USP 160 mg/12.5 mg by Macleods Pharmaceuticals Limited. The film-coated oral tablets come in a 90-count package. The label includes storage instructions and manufacturer details, indicating Macleods Pharma USA, Inc. in Princeton, NJ, and manufacturing in Daman, India.*

FDA Label Image

505 (Valsartan Hctz 160 25 90s Baddi)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/25 mg film-coated tablets in a 90-tablet package. The label includes storage instructions, pharmacist dispensing information, and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India. The label also displays the NDC number 33342-076-10.*

FDA Label Image

505 (Valsartan Hctz 160 25 90s Daman)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/25 mg, film-coated oral tablets. The package contains 90 tablets and is labeled for prescription use only. The label provides dosage and storage instructions and identifies Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. as the manufacturer and labeler.*

FDA Label Image

505 (Valsartan Hctz 320 12 5 90s Baddi)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/12.5 mg film-coated tablets by Macleods Pharmaceuticals Limited. The label includes dosage instructions, storage conditions, and manufacturer information for Macleods Pharma USA, Inc. It specifies a package count of 90 tablets and cautions to dispense with the patient information leaflet.*

FDA Label Image

505 (Valsartan Hctz 320 12 5 90s Daman)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, strength 320 mg/12.5 mg in film-coated tablet form. The label shows the product is manufactured by Macleods Pharmaceuticals Limited and labeled for Macleods Pharma USA, Inc. It contains 90 tablets and includes storage instructions and usual dosage reference. The label features barcodes, NDC 33342-077-10, and a note for pharmacists to dispense with the patient information leaflet.*

FDA Label Image

505 (Valsartan Hctz 320 25 90s Baddi)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/25 mg, film-coated tablets in a 90-tablet package. Manufactured by Macleods Pharma USA, Inc., with additional manufacturing by Macleods Pharmaceuticals Ltd. The label includes dosage strength, storage instructions, and barcode.*

FDA Label Image

505 (Valsartan Hctz 320 25 90s Daman)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/25 mg, film-coated oral tablets. Manufactured by Macleods Pharma USA, labeler Macleods Pharmaceuticals Limited. The package contains 90 tablets with usual dosage and storage instructions including storing at 20° to 25°C (68° to 77°F). Includes barcodes and instructions to dispense with the attached Patient Information Leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.